“Steven Salamon”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  4/29/24  as  ↓Signatory

        

As:  Group Member  (Co-Filer Non-Registrant:  Partner, Affiliate, etc.)

“Steven Salamon” has been a Group Member with  one  Filer:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/14/24			Rosalind Advisors, Inc.	52	SC 13G/A		MediWound Ltd.

“Steven Salamon” has/had a Group Member interest in  20  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
2/14/24			MediWound Ltd.	1	SC 13G/A		Rosalind Advisors, Inc.
7/21/22		NY	Delcath Systems, Inc.	11	SC TO-T/A		Rosalind Advisors, Inc.
7/6/22		GA	Guided Therapeutics Inc.	1	SC 13G		Rosalind Advisors, Inc.
3/9/22		CT	Trevi Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
2/14/22		PA	PhaseBio Pharmaceuticals Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
2/14/22		NJ	PLx Pharma Winddown Corp.	3	SC 13G/A		Rosalind Advisors, Inc.
2/11/22		PA	Galera Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
1/21/22		NJ	Cellectar Biosciences, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
1/20/22		CA	Unicycive Therapeutics, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
1/20/22		MA	Myomo, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
1/6/22		MA	Astria Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
1/22/21		CA	Vistagen Therapeutics, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
7/24/19		MA	Chiasma, Inc.	3	SC 13G/A		Rosalind Advisors, Inc.
2/14/19			Altamira Therapeutics Ltd.	2	SC 13G/A		Rosalind Advisors, Inc.
2/14/19		NJ	Tonix Pharmaceuticals Holding Corp.	4	SC 13G/A		Rosalind Advisors, Inc.
2/14/19		TX	Repros Therapeutics Inc.	3	SC 13G/A		Rosalind Advisors, Inc.
5/15/18			Purple Biotech Ltd.	2	SC 13G/A		Rosalind Advisors, Inc.
2/9/18		CA	Zosano Pharma Corp.	3	SC 13G/A		Rosalind Advisors, Inc.
2/9/18		MA	EyePoint Pharmaceuticals, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
2/12/16		MA	Albireo Pharma, Inc.	4	SC 13G/A		Rosalind Advisors, Inc.

“Steven Salamon” has been a Group Member with  7  other Group Members:

As Of	Group Member			Filings       #        Latest		With Filer     (Primary)		Issuer     (Primary)
2/14/24			Gil Aharon	13	SC 13G/A		Rosalind Advisors, Inc.		MediWound Ltd.
			Rosalind Advisors, Inc.	52
			Rosalind Master Fund L.P.	49
7/21/22		•	Rosalind Opportunities Fund L.P.	1	SC TO-T/A		Rosalind Advisors, Inc.	NY	Delcath Systems, Inc.
7/6/22		•	Gilad Aharon	5	SC 13G		Rosalind Advisors, Inc.	GA	Guided Therapeutics Inc.
3/9/22		•	Rosalind Opportunities Fund I L.P.	10	SC 13D/A		Rosalind Advisors, Inc.	NY	Delcath Systems, Inc.
1/2/18		•	Rosalind Capital Partners L.P.	11	SC 13G/A		Rosalind Advisors, Inc.	TX	Repros Therapeutics Inc.

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“Steven Salamon” has been a Signatory for/with  5  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
4/29/24		NY	Delcath Systems, Inc.	17	S-3	—
5/31/23		MA	Lyra Therapeutics, Inc.	2	8-K	—
5/11/23		PA	Galera Therapeutics, Inc.	1	10-Q	—
7/6/22			Rosalind Advisors, Inc.	11	SC 13G	GA	Guided Therapeutics Inc.
11/25/20			Salamon Steven A J	1	4	NY	Delcath Systems, Inc.

“Steven Salamon” has/had a Signatory interest in  9  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
7/6/22		GA	Guided Therapeutics Inc.	1	SC 13G		Rosalind Advisors, Inc.
3/9/22		CT	Trevi Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
3/9/22		NY	Delcath Systems, Inc.	2	SC 13D/A		Rosalind Advisors, Inc.
2/14/22		PA	PhaseBio Pharmaceuticals Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
2/11/22		PA	Galera Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
1/21/22		NJ	Cellectar Biosciences, Inc.	2	SC 13G/A		Rosalind Advisors, Inc.
1/6/22		MA	Astria Therapeutics, Inc.	1	SC 13G		Rosalind Advisors, Inc.
5/19/21		MA	Myomo, Inc.	1	SC 13G		Rosalind Advisors, Inc.
12/17/20		NJ	PLx Pharma Winddown Corp.	1	SC 13G		Rosalind Advisors, Inc.